HIV Waiting Room: Newly diagnosed transgender woman

This activity is jointly provided by Global Education Group and Integritas Communications.

This activity is supported by an educational grant from Gilead Sciences, Inc.

Target Audience

This activity is intended for infectious disease and HIV specialist physicians and other clinicians involved in the care of patients with HIV infection.

Statement of Need/Program Overview

Transgender patients face an increased risk of contracting HIV, and for those who are HIV positive, a unique set of challenges in treatment. This population achieves viral suppression less frequently than cisgender populations, making it essential for clinicians to understand the factors that determine this gap and optimal strategies to improve patient care.

This case-based, interactive activity focuses on transgender women with HIV, creating a clinical scenario addressing treatment initiation, incorporating gender-affirming hormone therapy into care, adherence, common comorbidities, and strategies to create a gender-affirming practice.

Educational Objectives

After completing this activity, the participant should be better able to:

• Implement strategies to overcome the barriers to and facilitate the benefits of timely HIV treatment initiation, including consideration of rapid ART protocols
• Describe the HIV treatment considerations unique to transgender women to improve engagement in care and optimize viral suppression

Faculty

Bruce Hinton PA-C, AAHIVMS
CrescentCare Health and Wellness Center
New Orleans, Louisiana

Carole Pindaro, APRN
CrescentCare
New Orleans, Louisiana

Physician Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and Integritas.  Global is accredited by the ACCME to provide continuing medical education for physicians.

Physician Credit Designation

Global designates this enduring activity for a maximum of 0.5 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Global Contact Information

For information about the accreditation of this program, please contact Global at 303-395-1782 or cme@globaleducationgroup.com.

Instructions to Receive Credit

In order to receive credit for this activity, the participant must complete the posttest and program evaluation. Your posttest will automatically be graded. If you successfully complete the posttest (score of 65% or higher), your statement of participation will be made available immediately. Click on the View Statement of Participation link and print the statement for your records. If you receive a score lower than 65%, you will receive a message notifying you that you did not pass the posttest. You will have 2 opportunities to pass the posttest.

Fee Information& Refund/Cancellation Policy

There is no fee for this educational activity.

Disclosure of Conflicts of Interest

Global requires instructors, planners, managers, and other individuals and their spouses/life partners who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

The faculty reported the following financial relationships or relationships to products or devices they or their spouses/life partners have with commercial interests related to the content of this CME activity:

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouses/life partners have with commercial interests related to the content of this CME activity:

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global and Integritas do not recommend the use of any agent outside of the labeled indications.  

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

COURSE VIEWING REQUIREMENTS